90Y-Pentixather

N/A

Report date: 2025/11/20 11:38:24
NME

Base Information

Drug Name90Y-Pentixather
Drug Alias Name[90Y] Pentixather90Y Pentixather[90Y]Y-PTT Endoradiotherapy[90Y]Y-PentixaTher[90Y]Y-PTT +[8] 
ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Yttrium > 90YRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionC-X-C motif chemokine receptor 4 modulatorsIonising radiation emittersPositron-emission tomography enhancers
TargetsC-X-C motif chemokine receptor 4
Therapy Area/IndicationsCentral Nervous System LymphomaMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of WurzburgTechnical University Of Munich
China Registration ClassN/A

Develop Information

Active CompaniesPentixapharm AG
Inactive CompaniesUniversity Of WurzburgTechnical University Of Munich
Active IndicationsCentral Nervous System Lymphoma
Inactive IndicationsMultiple Myeloma

Other Information

ATC CodeN/A
Related LinksN/A